Renub Research study titled “Alzheimer’s Pipeline Drugs Review, Alzheimer’s Disease Drug Market & Forecast – Global Analysis” provides a comprehensive assessment of the fast-evolving, high-growth Global Alzheimer’s Disease Market. This 110 page report with 29 Figures and 11 Tables studies the Global Alzheimer’s Disease Drug Market.
Present & Pipeline Drugs Studied in this Report
1. Namenda
2. Ebixa
3. Axura
4. Aricept
5. Nootropil
6. Exelon
7. Memary
8. Solanezumab
9. LuAe58054
This report contains 10 chapters.
(Chapter 1): Executive Summary
(Chapter 2): This Chapter is divided into 2 parts
A. Alzheimer’s Disease Drug Market & Forecast data available from 2003 to 2018
B. Unmet Alzheimer’s Disease Drug Market & Forecast (Market Potential) data available from 2010 to 2018. (Unmet market is the potential market which could have been achieved if right drug have been introduced in the market)
(Chapter 3): This chapter talks about drugs which has failed while in Clinical trials
(Chapter 4): This chapter provides Market Share of Alzheimer’s Disease Drug from 2003 to 2018. All the 9 Alzheimer’s drug mentioned above have been covered in this chapter.
(Chapter 5): This chapter talks about Alzheimer’s Drugs performance. All important drugs mentioned above past, present & future market data available from 2003 to 2018.
(Chapter 6): Pipeline drugs (Solanezumab, LuAE58054, Gantenerumab, Crenezumab, TRx0237 (LMTX), MK-8931, ABT-126, AZD-1446) have been analyzed in this chapter. All drugs have been analyzed from 5 view points:
A. Clinical Development Stage
B. Pipeline Drug Sales Performance
C. Recent Clinical Development
D. Different Companies Deal
E. Investment
(Chapter 7): This chapter speaks of Alzheimer’s Drugs Company deals in four areas
A. Strategic Alliances in Alzheimer’s Disease Drug Market
B. Licensing Agreement in Alzheimer’s Disease Drug Market
C. Collaboration Deal in Alzheimer’s Disease Drug Market
D. Merger & Acquisition in Alzheimer’s Disease Drug Market
(Chapter 8): This chapter studies Funding in Alzheimer’s Disease Drugs Research. We have covered 5 institutes which provides fund for the research.
A. National Institute of Health
B. Alzheimer's Association
C. Cure Alzheimer’s Fund
D. Alzheimer’s Drug Discovery Foundation
E. BrightFocus Foundation [formerly American Health Assistance Foundation (AHAF)]
(Chapter 9): This chapter studies Growth Factors Driving the Alzheimer’s Disease Drug Market.
(Chapter 10): This chapter studies Challenges/Hindrances faced by Alzheimer’s Disease Drug Market.
Contact Us
Andy Hill
Sr. Manager - Publisher Relation
Sales & Marketing Div.
Renub Research
Email: info@renub.com
Phone: +1-678-302-0700 (USA) , +91-120-4219-822, +91-120-254-5750 (India)
Web: http://www.renub.com/